Oncolytics Biotech Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) Transcript
Good morning, everyone, and welcome to our Horizons in Oncology Conference with Oncolytics. Joining us from the Oncolytics team is Dr. Tom Heineman, the Chief Medical Officer from Oncolytics. I'm John Newman, one of the senior advising analysts here at Canaccord Genuity. We will be conducting a question-and-answer this morning with Dr. Heineman, but we will also be taking questions from the webcast. (Conference Instructions)
Questions & Answers
So, Tom, good morning. Thank you very much for joining us. So I was wondering if you could begin by just giving us an overview of the pelareorep program, including the therapeutic settings where you think that this approach could be most effective. Thanks.
Yes, thank you, John, very much. I'm happy to be here. So as you know, our most advanced data using pelareorep in a clinical setting is in metastatic breast cancer.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
